相关实验视频

Updated: Mar 9, 2026

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

向 metionin 诱导的烧死会增强抗瘤免疫力

Mingzhu Lei¹, Wenying Zhu¹, Chao Wang¹

¹Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Radiation Oncology; Shanghai Key Laboratory of Medical Epigenetics; National Key Laboratory of Brain Function and Diseases; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

Science China. Life sciences

|March 7, 2026

概括

metionin 的新陈代谢调节 pyroptosis,细胞死亡对于瘤免疫至关重要. 用像PGG这样的化合物准甲氨基基转移酶2A (MAT2A) 诱导热亡并抑制瘤生长.

科学领域:

免疫学免疫学免疫学
代谢途径代谢途径
癌症研究癌症研究

背景情况:

炎症性细胞死亡的 Pyroptosis 在瘤免疫力中至关重要.
热致死的代谢调节者尚未完全理解.
甲氨酸代谢在热致死中的作用尚未被探索.

研究的目的:

为了研究 metionin 代谢在 pyroptosis 中的作用.
为了确定用于调节癌症中皮रोप托斯的代谢标.

主要方法:

利用骨髓衍生的巨细胞 (BMDMs) 来研究热.
研究了氨酸腺转移酶2A (Mat2a) 枯竭和抑制的影响.
评估了1,2,3,4,6-O-pentagalloylglucose (PGG) 对MAT2A活性和降解的影响.
通过Gasdermin E (GSDME) 和Gasdermin D (GSDMD) 激活,评估了通过Pyroptosis诱导.
在体内检查了瘤生长抑制和抗瘤免疫反应.

主要成果:

在BMDMs中Mat2a的枯竭通过激活GSDME诱导热,抑制瘤生长.
对MAT2A的药理抑制通过GSDME引发了巨细胞灭,而不是GSDMD.
自然化合物PGG抑制了MAT2A的活性,并促进了它的降解.
通过在瘤细胞中裂解GSDME,PGG诱导了烧,增强了抗瘤免疫力.

结论:

氨酸代谢,特别是MAT2A,是热的关键调节者.
用PGG准MAT2A显示了通过诱导热和增强抗瘤免疫力来治疗癌症的潜力.

关键词:

在GSDME中,GSDME是GSDME.这就是 MAT2A.巨细胞是一个巨细胞.热致灭症是什么?瘤免疫力免疫力

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...